Effect of supplementation in treatment of patients with polycystic ovary syndrome
Phase 2
- Conditions
- Polycystic ovary syndrome.Polycystic ovary syndrome
- Registration Number
- IRCT201612315623N97
- Lead Sponsor
- Vice chancellor of research, Bushehr University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 40
Inclusion Criteria
Patients with polycystic ovary syndrome; aged 18 to 40 years. Exclusion criteria: Unwillingness to cooperate.
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method TNF-a. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: PCR-RT.;IL-1. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: PCR-RT.
- Secondary Outcome Measures
Name Time Method Ox-LDL. Timepoint: At the beginning of the study and after 12 weeks of intervention. Method of measurement: PCR-RT.